Product Information
XIGDUO XR 5 MG-500 MG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $19.1833 per EA under NDC 00310625030. Its NADAC has been published 584 times since Jun 17, 2015.
FDA first approved this application on Oct 29, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 500 mg/1; mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310625030
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205649FDA Approved
10/29/2014
TE Code
AB
On Market Since
10/29/2014
Pharmacological Classes
Price Statistics
The NADAC for XIGDUO XR 5 MG-500 MG TABLET has been published 584 times since Jun 17, 2015, and over the history we have for it it has risen 73.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.1833 per EA |
|---|---|
| All-time high | $19.2049 (May 14, 2025) |
| All-time low | $11.0798 (Jun 17, 2015) |
| 52-week high | $19.1892 |
| 52-week low | $19.1568 |
| Median price | $16.9900 |
| Average price | $16.2942 |
| Largest weekly change | +8.6% (Jan 18, 2017) |
| Weeks tracked | 584 |
| Tracking since | Jun 17, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dapagliflozin and metformin hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of XIGDUO XR 5 MG-500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for XIGDUO XR 5 MG-500 MG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $19.1833 per EA (NDC 00310625030), effective Aug 19, 2026.
How has the price of XIGDUO XR 5 MG-500 MG TABLET changed over time?
Over the history we have for it, the NADAC for XIGDUO XR 5 MG-500 MG TABLET has risen 73.1%. It has been tracked across 584 weekly CMS publications since Jun 17, 2015.
What are the highest and lowest recorded NADAC prices for XIGDUO XR 5 MG-500 MG TABLET?
Since Jun 17, 2015, the NADAC for XIGDUO XR 5 MG-500 MG TABLET has ranged from a low of $11.0798 (Jun 17, 2015) to a high of $19.2049 (May 14, 2025), with a median of $16.9900 per EA.
Are there cheaper alternatives to XIGDUO XR 5 MG-500 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of XIGDUO XR 5 MG-500 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures XIGDUO XR 5 MG-500 MG TABLET?
XIGDUO XR 5 MG-500 MG TABLET (NDC 00310625030) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.